Arcus Biosciences (RCUS) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Arcus Biosciences (RCUS) over the last 7 years, with Q3 2025 value amounting to -$1.27.
- Arcus Biosciences' EPS (Weighted Average and Diluted) fell 2700.0% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.44, marking a year-over-year decrease of 920.63%. This contributed to the annual value of -$3.14 for FY2024, which is 2431.43% up from last year.
- As of Q3 2025, Arcus Biosciences' EPS (Weighted Average and Diluted) stood at -$1.27, which was down 2700.0% from -$1.14 recorded in Q1 2025.
- Arcus Biosciences' 5-year EPS (Weighted Average and Diluted) high stood at $3.99 for Q4 2021, and its period low was -$1.27 during Q3 2025.
- Over the past 5 years, Arcus Biosciences' median EPS (Weighted Average and Diluted) value was -$1.01 (recorded in 2024), while the average stood at -$0.66.
- The largest annual percentage gain for Arcus Biosciences' EPS (Weighted Average and Diluted) in the last 5 years was 55862.07% (2021), contrasted with its biggest fall of 380000.0% (2021).
- Arcus Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at $3.99 in 2021, then crashed by 123.31% to -$0.93 in 2022, then decreased by 16.13% to -$1.08 in 2023, then grew by 3.4% to -$1.04 in 2024, then decreased by 21.73% to -$1.27 in 2025.
- Its EPS (Weighted Average and Diluted) was -$1.27 in Q3 2025, compared to -$1.14 in Q1 2025 and -$1.04 in Q4 2024.